期刊文献+

乳腺癌中PTEN蛋白表达及其与ER和PR表达的相关性

Expression of PTEN,ER and PR and Relationship between Them in Breast Carcinoma
下载PDF
导出
摘要 目的探讨乳腺癌中PTEN抑癌基因表达和ER、PR表达之间的关系。方法采用免疫组化S-P法分别检测80例乳腺癌及癌旁组织中PTEN蛋白及ER、PR的表达。结果PTEN蛋白在乳腺癌组织中的阳性表达率显著低于癌旁组织,两者相比差异有显著性(P<0.01)。PTEN蛋白在淋巴结转移组中的阳性表达率明显低于淋巴结无癌转移组(P<0.01)。PTEN蛋白分别和ER、PR在80例乳腺癌中的表达呈正相关(P<0.05;P<0.05)。结论PTEN蛋白的表达缺失与ER、PR表达失衡在乳腺癌的发生、发展中起重要作用。 Objective To study the expression of the PTEN tamor suppressor gene, estrogen receptor( ER), progesterone receptor (PR) and relationship between them in breast carcinoma. Methods lmmunohistochemistry (SP) was used to detect the expression of ER, PR, and FTEN in 80 breast carcinomas and nearby no tumorous tissues. Results The positive expression rate of FInN in breast carcinoma was significantly lower than that in nearby no-tumorous tissues ( P〈0.01 ) . There was also significant difference of PTEN protein expression between breast careinomas with lymph node metastasis and without lymph node metastasis ( P〈0.01 ) . The positive expression of FFEN protein was positively correlated with the expression of ER and PR ( P〈0.05 ; P〈0.05) . Conclusion The down regulation of PTEN and the imbalaneed expression of ER and PR in breast carcinomas played an important role in the development and progression of the cancer.
出处 《湘南学院学报(自然科学版)》 2005年第3期1-3,8,共4页
关键词 乳腺癌 免疫组织化学 PTEN ER PR Breast carcinomas lmmunohistochemistry PTEN ER PR
  • 相关文献

参考文献11

  • 1吴元清,魏启幼.PTEN在乳腺癌研究中的进展[J].国外医学(生理病理科学与临床分册),2003,23(6):577-580. 被引量:9
  • 2[2]Weng LP,Brown JL,Eng C,et al.PTEN coordinates G1 arrest by down-regulating cyclin D1 via its protein phosphatase activity and up-regulating P27 via its lipid posphatase activitv in a breast cancer model[J].Human molecular genetics,2001,10(6):599-604.
  • 3[3]Perren A,Weng LP,Boag AH,et al.Immunohistochemical evidence of loss of PTEN expression in primary ductal adenocarcinomas of the breast[J].The American journal of pathology,1999,155(4):1253-1260.
  • 4[4]Bose S,Crane A,Hibshoosh H,et al.Reduced expression of PTEN correlates with breast cancer progression[J].Human pathology,2002,33(4):405-409.
  • 5[5]Tamura M,Gu J,Matsumoto K,et al.Inhibition of cell migration,spreading,and focal adhesions by tumor suppressor PTEN[J].Science,1998,280(5369):1614-1617.
  • 6[6]Stambolic V,Tsao MS,Macpherson D,et al.High incidence of breast and endometrial neoplasia resembling human Gowden syndrome in pten +/-mice[J].Cancer Research,2000,60(13):3605-3611.
  • 7[7]Bose S,Wang SI,Terry MB,et al.Allelic loss of chromosome 10q23 is associated with tumor progression in breast carcinomas[J].Oncogene,1998,17(1):123-127.
  • 8[8]Shi W,Zhang X,Pintilie M,et al.Dysregulated PTEN-PKB and negative receptor status in human breast cancer[J].International journal of cancer,2003,104(2):195-203.
  • 9[9]Nakatani K,Thompson D A,Barthel A.et al.Up-regulation of Akt3 in estrogen receptor-deficient breast cancers and androgen-independent prostate cancer lines[J].The Journal of biological chemistry,1999,274(31):21528-21532.
  • 10[10]Campbell RA,Bhat-Nakshatri P,Patel NM,et al.Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor alpha:a new model for anti-estrogen resistance[J].The Journal of biological chemistry,2001,276(13):9817-9824.

二级参考文献23

  • 1Lee J, Georgescu M, Di Cristofano A, et al. Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association [ J ]. Cell, 1999,99 ( 3 ):323 -334.
  • 2Maehama T, Dixon JE. The tumor suppressor,PTEN/MMAC1 ,dephosphorilates the lipid second messenger, phosphatidylinosital-3,4,5-trisphosphate [ J ]. J Biol Chem, 1998, 273 ( 22 ): 13375-13378.
  • 3Wu X, Hepner K, Castelino-Prabhu S, et al. Evidence for regulation of the PTEN tumor suppressor by a membrane-localized multiPDZ domain containing scaffold protein MAGI-2 [ J]. Proc Natl Acad Sic USA,2000, 97 ( 8 ) :4233-4238.
  • 4Georgescu M, Kirsch K, Adage T, et al. The tumor-suppressor activity of PTEN is regulated by its carboxyl-terminal region[ J]. Cell Biology, 1999, 96( 18 ): 10182-10187.
  • 5Vazquez F, Ramaswamy S, Nakamura N, et al. Phosphorylation of the PTEN tail regulates protein stability and function[J]. Mol Cell Biol, 2000,20(14) :5010-5018.
  • 6Lu Y, Lin YZ, LaPushin R, et al. The PTEN/MMACl/TEP tumor suppressor gene decreases cell growth and induces apoptosis and anoikis in breast cancer cells[J]. Oncogene, 1999, 18(50) :7034-7045.
  • 7Weng LP, Brown JL, Eng C, et al. PTEN coordinates Gl arrest by down-regulating cyclin Dl via its protein phosphatase activity and up-regulating p27 via its lipid phosphatase activity in a breast cancer model [ J ]. Hum Mol Genet, 2001 , 10 ( 6 ) :599-604.
  • 8Haas-Kogan D, Shalev N, Wong M, et al. Protein kinase B(PKB/Akt ) activity is elevated in glioblastoma cells due to mutation of the tumor suppressor PTEN/MMAC [J]. Curr Biol, 1998,8 ( 21 ):1195-1198.
  • 9Li DM, Sun H. PTEN/MMACl/TEP1 suppresses the tumorigenicity and induces Gl cell cycle arrest in human glioblastoma cells[ J].Proc Nad Acad Sic USA, 1998, 95 (26): 15406-15411.
  • 10Weng LP, Smith WM, Dahia PL, et al. PTEN suppresses breast cancer cell growth by phospbatase activity-dependent Gl arrest followed by cell death [ J ]. Cancer Res, 1999,59 ( 22 ): 5808-5814.

共引文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部